Key Highlights
- Cross Country Healthcare Inc. Is set to hold a special stockholder meeting on July 16, 2026, to discuss a proposed merger.
- The proxy statement indicates that eligible stockholders must be on record by June 12, 2026, to vote on the merger proposal.
- Cross Country’s estimated net cash stands at approximately $106.2 million as it anticipates finalizing the merger by Q3 of 2026.
Cross Country Healthcare Inc. (NASDAQ: CCRN) is moving forward with plans for a significant merger, announcing a special meeting for stockholders to take place on July 16, 2026. The gathering aims to secure approval for the merger with KL Criss Cross Intermediate, LLC, and its subsidiary, KL Criss Cross Merger Sub, Inc. To cement the company's status as a wholly-owned subsidiary of the parent entity.
Special Meeting Scheduled
The special meeting is an essential part of the merger process, which requires shareholder approval for its consummation. Stockholders of record as of June 12, 2026, will have the opportunity to cast their votes during this pivotal meeting scheduled for noon Eastern Time on July 16. As of this date, approval from stockholders is critical for the anticipated closure of the merger, targeted for the third quarter of 2026.
Legal Scrutiny Intensifies
Cross Country is currently facing multiple lawsuits filed by purported stockholders alleging deficiencies in the merger's proxy statement. Attorneys have issued demand letters claiming that certain disclosures are inadequate. If these demands remain unaddressed, the stockholders threaten to pursue legal action, although no lawsuits have been formally filed as of yet.
Supplemental Proxy Disclosures
In response to ongoing legal concerns, Cross Country Healthcare has opted to voluntarily supplement its proxy statement with additional disclosures. While the company maintains that the allegations made in the lawsuits are without merit, it aims to mitigate any risks associated with the merger process. These disclosures offer clarity on the interests of the directors and executive officers, who may possess different advantages in relation to shareholders in the wake of the proposed merger.
Financial Position Detailed
As part of the merger preparations, financial assessments have been conducted by BofA Securities, revealing that Cross Country's estimated net cash amounts to approximately $106.2 million. This figure will be factored into the overall valuation, which involves calculating its enterprise value based on projected earnings before interest, taxes, depreciation, and amortization (EBITDA). Scenarios derived from historical enterprise value to EBITDA multiples in similar transactions suggest a potential value range for Cross Country's equity per share around $0.05 increments.
Market Comparisons Made
A structured review by BofA Securities included an analysis of enterprise value to earnings before interest, taxes, depreciation, and amortization (EBITDA) multiples for companies in the healthcare staffing sector. The findings indicated a range of low to high enterprise value multiples from about 8.9x to 11.5x. Such benchmarks support assessments for Cross Country’s equity amid ongoing market conditions and competitive landscapes in the healthcare staffing industry.
Directors’ Motivations Explored
As the merger discussions progress, the interests of Cross Country's directors and executive officers have raised considerations distinct from the general stockholder population. These interests include the potential vesting of equity awards, severance arrangements, and ongoing insurance coverage rights. The board evaluated these considerations thoroughly during the negotiation of the merger agreement to align with the best interests of shareholders.
FAQs
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.


_11_19_2026_12_58_12_592184.jpg)



Please wait processing your request...